Regulation of immune-related diseases by multiple factors of chromatin, exosomes, microparticles, vaccines, oxidative stress, dormancy, protein quality control, inflammation and microenvironment: a meeting report of 2017 International Workshop of the Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine on Tumor Immunology

Bing Cui, Xuetao Cao, Weiping Zou, Yonghong Wan, Ning Wang, Yaohe Wang, Pingping Li, Fang Hua, Yuying Liu, Xiaowei Zhang, Ke Li, Xiaoxi Lv, Bo Huang, Zhuowei Hu

Research output: Contribution to journalArticlepeer-review

Abstract

Immune cells play key roles in cancer and chronic inflammatory disease. A better understanding of the mechanisms and risks will help develop novel target therapies. At the 2017 International Workshop of the Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine on Tumor Immunology held in Beijing, China, on May 12, 2017, a number of speakers reported new findings and ongoing studies on immune-related diseases such as cancer, fibrotic disease, diabetes, and others. A considerably insightful overview was provided on cancer immunity, tumor microenvironments, and new immunotherapy for cancer. In addition, chronic inflammatory diseases were discussed. These findings may offer new insights into targeted immunotherapy.

Original languageEnglish (US)
Pages (from-to)532-540
Number of pages9
JournalActa Pharmaceutica Sinica B
Volume7
Issue number4
DOIs
StatePublished - Jul 2017

Keywords

  • Chromatin
  • Dormancy
  • Exosomes
  • Immunology
  • Inflammation
  • Microparticles
  • Oxidative stress
  • Protein Quality Control
  • Tumor
  • Vaccines

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint Dive into the research topics of 'Regulation of immune-related diseases by multiple factors of chromatin, exosomes, microparticles, vaccines, oxidative stress, dormancy, protein quality control, inflammation and microenvironment: a meeting report of 2017 International Workshop of the Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine on Tumor Immunology'. Together they form a unique fingerprint.

Cite this